Q2 FY26 standalone revenue ₹567.5 crore with 7.9% YoY growth; H1 revenue ₹1,119.2 crore; EBITDA margins expanded to 11.1% in Q2 and 11.8% in H1; PAT ₹30.0 crore in Q2 and ₹64.0 crore in H1; Cash PAT ₹51.5 crore (Q2) and ₹106.3 crore (H1).
AI Assistant
IOL Chemicals & Pharmaceuticals Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.